Medical Center Kazanlak EOOD

The Endocrinology consulting room at Medical Center Kazanlak EOOD focuses on nutritional and metabolic diseases, aiming to improve outcomes for patients with obesity, with or without type 2 diabetes. Current research evaluates the weight‑loss potential of a combined therapy using Semaglutide and Cagrilintide as an adjunct to diet and exercise. The goal is to determine whether the new combination achieves greater body‑weight reduction than standard dosing.

• Body weight reduction assessment
• Adjunct to reduced‑calorie diet
• Physical activity enhancement

These investigations are conducted at the Kazanlak site, offering participants access to cutting‑edge metabolic care.

In the same department, investigators study skin and connective tissue diseases, with a focus on moderate‑to‑severe atopic dermatitis. A key trial compares the investigational antibody camoteskimab against placebo to assess clinical efficacy. The study seeks to improve symptom control and quality of life for affected adults.

• Moderate-to-severe disease focus
• Antibody therapeutic evaluation
• Quality‑of‑life outcomes

Patients enrolled at Medical Center Kazanlak EOOD benefit from specialized dermatologic assessment within the endocrinology clinic.